Stivarga 40 mg | Advanced Liver & Colon Cancer Treatment | No Style Like

EGP26645

NameStivarga 40 mg 28 film-coated tablets
BrandBayer
Strength40 mg
Quantity / Size28 tablets
FormFilm-coated tablets
AppearanceWhite-blue carton box containing blister packs
Expiry DateVaries by batch (check packaging)
Country of OriginGermany
Product CodeSTIV-40-28BAYER

Stivarga 40 mg by Bayer is indicated for advanced liver and colorectal cancer. It contains Regorafenib, a multi-kinase inhibitor that slows tumor growth and improves survival.
Description

⚡ Quick Answer

Stivarga 40 mg (Regorafenib) is an advanced targeted therapy designed to treat certain types of cancer, particularly hepatocellular carcinoma (HCC), also known as liver cancer, and metastatic colorectal cancer (mCRC). Manufactured by Bayer Pharmaceut

Introduction

Stivarga 40 mg (Regorafenib) is an advanced targeted therapy designed to treat certain types of cancer, particularly hepatocellular carcinoma (HCC), also known as liver cancer, and metastatic colorectal cancer (mCRC). Manufactured by Bayer Pharmaceuticals, this medication offers new hope for patients whose cancer has progressed after standard therapies.


✅ What is Stivarga 40 mg?

Stivarga contains the active ingredient Regorafenib, a multi-kinase inhibitor that blocks abnormal pathways responsible for cancer cell growth, angiogenesis (blood vessel formation), and metastasis. By inhibiting these pathways, Stivarga helps slow down the progression of cancer and improves overall survival.


✅ Indications

Stivarga is prescribed for:

  1. Advanced liver cancer (HCC) when prior treatment with sorafenib fails.

  2. Metastatic colorectal cancer (mCRC) after failure of conventional therapies.

  3. Gastrointestinal stromal tumors (GISTs) when other treatments are ineffective.


✅ Mechanism of Action

Stivarga acts as a multi-kinase inhibitor targeting tumor growth and angiogenesis. It blocks:

  • Vascular endothelial growth factor receptors (VEGFR1-3).

  • Platelet-derived growth factor receptor (PDGFR).

  • Oncogenic kinases such as KIT, RET, and RAF.

This action prevents tumor cells from receiving nutrients and oxygen, thereby inhibiting tumor growth and spread.


✅ Dosage and Administration

  • Recommended dose: 160 mg daily (4 tablets × 40 mg each).

  • Treatment cycle: Taken once daily for 3 weeks, followed by 1 week off.

  • Administration: Tablets must be taken after a low-fat meal.

  • Dosage adjustments may be required depending on side effects or tolerance.

⚠️ Patients should never self-adjust the dose without medical supervision.


✅ Side Effects

Like other cancer treatments, Stivarga may cause side effects, including:

  • Fatigue and weakness

  • Loss of appetite and weight loss

  • High blood pressure

  • Abdominal pain or diarrhea

  • Hand-foot skin reactions (redness, blisters, peeling)

  • Elevated liver enzymes (requires monitoring)

⚠️ Serious adverse reactions may include severe bleeding, liver toxicity, or heart problems. Patients must seek medical help if they notice yellowing of the skin, dark urine, or chest pain.


⚠️ Important Warning

Do not exceed the recommended dose. Keep out of reach of children. Not for pregnant or nursing women unless advised by a healthcare professional.

✅ Contraindications

  • Known hypersensitivity to Regorafenib or any component.

  • Patients with severe liver impairment.

  • Not recommended during pregnancy or breastfeeding.


✅ Drug Interactions

Stivarga may interact with:

  • Antibiotics such as rifampin.

  • Antifungal drugs like ketoconazole.

  • Blood thinners (e.g., warfarin) requiring dose adjustment.

  • Proton pump inhibitors (PPIs) which may reduce absorption.


✅ Availability

Stivarga is available in 40 mg film-coated tablets (28 tablets per box). The product is manufactured in Germany by Bayer and distributed worldwide under strict medical supervision.


⭐ User Reviews

⭐⭐⭐⭐⭐ “Stivarga gave me another chance after other treatments failed.”
⭐⭐⭐⭐ “The side effects are there, but manageable with medical guidance.”
⭐⭐⭐⭐⭐ “Authentic Bayer product. Very effective and reliable.”



❓ Frequently Asked Questions (FAQs)

1. What is Stivarga used for?
It is used for advanced liver, colorectal, and gastrointestinal stromal tumors.

2. How does Stivarga work?
It blocks cancer growth and angiogenesis by inhibiting multiple kinases.

3. What is the usual dose?
160 mg daily (4 × 40 mg tablets) for 3 weeks, followed by 1 week off.

4. Can Stivarga cause side effects?
Yes, including fatigue, diarrhea, weight loss, and high blood pressure.

5. Is Stivarga safe during pregnancy?
No, it should not be used during pregnancy or breastfeeding.

6. Can I take Stivarga with other medicines?
It may interact with antibiotics, antifungals, and blood thinners.

7. How should I take the tablets?
Always after a light, low-fat meal, at the same time each day.

8. Is it a cure for cancer?
No, but it slows progression and improves survival rates.

9. What does the packaging look like?
A white and blue box containing 28 film-coated tablets.

10. Where can I buy Stivarga?
From licensed pharmacies or No Style Like store.

⚠️ Medical Disclaimer

This content is for informational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting any supplement. Individual results may vary.

Reviewed by Dr. Abdallah Fouad, Clinical Nutrition Specialist — 25+ years of experience.

⚕️ Medical Disclaimer:
The information provided on this page is for educational and informational purposes only and is not a substitute for professional medical advice. Do not use any medication or dietary supplement without consulting your doctor or licensed pharmacist. Read the full medical disclaimer policy
✅ This content has been reviewed by Dr. Abdallah Fouad — Clinical Nutrition Specialist (25+ years of experience).